Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Integrated Assessment of Amiodarone Effects in Paroxysmal Atrial Fibrillation
NCT07487714Phase 4Enrolling by invitation
- Sponsor
- Tomsk National Research Medical Centre of the Russian Academy of Sciences
- Start
- Jan 2026
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of amiodarone in Atrial fibrillation (AFib), sponsored by Tomsk National Research Medical Centre of the Russian Academy of Sciences. Started Jan 2026; status: enrolling by invitation.
02
Drugs
amiodarone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT07487714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07487714.